Art Papier, M.D., CEO of VisualDx, says darker skin tones have been underrepresented in dermatology resources for decades and ...
The American Academy of Ophthalmology (AAO) kicked off their 2026 annual meeting today in New Orleans, with an authentic second-line parade of musicians, dancers and performers inviting conference ...
Large language models (LLMs) are now bringing new attention to the category, according to Art Papier, M.D., CEO of VisualDx. He also cautions that clinicians shouldn’t assume these tools are always ...
Real-world data at the 2026 Fall Clinical Dermatology Conference show dupilumab in children with atopic dermatitis cuts new ...
Sagimet CEO David Happel says oral denifanstat could sharply cut antibiotic use in acne and be used before patients ever need ...
The lawsuit targets the Global Benchmark for Efficient Drug Pricing (GLOBE) Model, a mandatory model CMS finalized last week ...
The 2026 Pharmacy Benefit Management Institute Annual National Conference was held Sept. 10-11 in Orlando, Florida. Here is a ...
Sagimet Biosciences’ denifanstat oral acne pill shows rapid, sustained lesion cuts and higher clear-skin rates in phase 3, ...
Sagimet Biosciences has begun screening patients for a U.S. phase 3 trial of denifanstat, an investigational once-daily oral ...
Pills that rival biologics, weight-loss drugs paired with psoriasis treatment and a phase 3 win for a personalized mRNA ...
The CEO and founder of a digital behavior company has advice for health plans considering asynchronous behavioral health ...
New guidelines for acute low back pain favors self-care, NSAIDs, physical therapy and acupuncture over routine imaging and first-line opioids. Imaging and opioids should not be first-line treatment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results